Related Experiment Videos
Cell adhesion molecules in coronary artery disease
Y Jang1, A M Lincoff, E F Plow
1Center for Thrombosis and Vascular Biology, Cleveland, Ohio.
Journal of the American College of Cardiology
|December 1, 1994
Summary
Cell adhesion molecules mediate cell interactions crucial for cardiovascular health. Understanding these molecules, like integrins, informs new therapeutic strategies for diseases such as atherosclerosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Six families of cell adhesion molecules (CAMs) are known: integrins, selectins, immunoglobulin superfamily, cadherins, proteoglycans, and mucins.
- CAMs are cell surface receptors mediating cell-cell and cell-extracellular matrix interactions.
- These interactions are vital in various cell types, including endothelium, monocytes, smooth muscle cells, platelets, and leukocytes.
Purpose of the Study:
- To review the clinically relevant biology of cell adhesion molecule families.
- To establish a foundation for understanding their emerging role in cardiovascular therapeutics.
Main Methods:
- Literature review of cell adhesion molecule biology.
- Analysis of clinical trial data demonstrating the therapeutic potential of targeting CAMs.
Main Results:
- Clinical trials using anti-integrin antibody fragments show reduced arterial thrombosis and restenosis post-intervention.
- CAMs play fundamental roles in atherosclerosis, acute coronary syndromes, reperfusion injury, and allograft vasculopathy.
Conclusions:
- Cell adhesion molecules are critical targets for cardiovascular therapeutics.
- Further research into CAMs will advance the treatment of cardiovascular diseases.